CEPO vs SABS
Comparison between Cantor Equity Partners I Inc - Class A (CEPO, Company) and SAB Biotherapeutics Inc (SABS, Company).
CEPO is from the Financial Services sector, while SABS is from the Healthcare sector.
CEPO vs SABS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CEPO vs SABS - Historical Returns
Returns include dividend reinvestment.
CEPO vs SABS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | CEPO | SABS |
|---|---|---|
| 2026 | +2.40% | -6.90% |
| 2025 | +3.58% | +0.81% |
| 2024 | N/A | -45.80% |
| 2023 | N/A | +5.77% |
| 2022 | N/A | -93.06% |
| 2021 | N/A | -23.05% |
CEPO vs SABS Drawdown Comparison
The maximum drawdown for CEPO was -42.06%, occurring on Jun 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for SABS was -99.01%, occurring on Apr 7, 2025. This drawdown has not yet recovered.
The current CEPO drawdown is -30.05%. The current SABS drawdown is -96.88%.
| Rank | CEPO | SABS |
|---|---|---|
| #1 | -42.06% Jul 16, 2025 - Jun 30, 2026 | -99.01% Dec 1, 2021 - Apr 7, 2025 |
| #2 | -10.64% May 12, 2025 - Jul 15, 2025 | -30.28% Oct 18, 2021 - Nov 17, 2021 |
| #3 | -3.41% May 2, 2025 - May 9, 2025 | -23.01% Nov 17, 2021 - Dec 1, 2021 |
| #4 | -0.60% Apr 28, 2025 - May 1, 2025 | -6.07% Feb 18, 2021 - Oct 18, 2021 |
| #5 | -0.44% Feb 12, 2025 - Mar 19, 2025 | -0.64% Feb 10, 2021 - Feb 12, 2021 |
| #6 | -0.39% Apr 3, 2025 - Apr 14, 2025 | -0.64% Feb 16, 2021 - Feb 18, 2021 |
| #7 | -0.34% Mar 27, 2025 - Apr 1, 2025 | N/A |
| #8 | -0.29% Apr 15, 2025 - Apr 23, 2025 | N/A |
| #9 | -0.24% Apr 1, 2025 - Apr 3, 2025 | N/A |
| #10 | -0.20% Jan 17, 2025 - Feb 5, 2025 | N/A |
| #11 | -0.20% Mar 19, 2025 - Mar 25, 2025 | N/A |
| #12 | -0.10% Jan 14, 2025 - Jan 17, 2025 | N/A |
| #13 | -0.03% Feb 10, 2025 - Feb 12, 2025 | N/A |
Correlation
Correlation between CEPO and SABS is -0.40 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks